CA Stock MarketDetailed Quotes

MediPharm Labs Corp (LABS)

Watchlist
  • 0.090
  • +0.010+12.50%
15min DelayMarket Closed May 13 16:00 ET
38.24MMarket Cap0.00P/E (TTM)

MediPharm Labs Corp (LABS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
7.54%45.12M
-8.14%11.06M
16.84%11.45M
14.09%11.81M
10.59%10.81M
26.92%41.96M
31.88%12.04M
15.20%9.8M
8.00%10.35M
67.23%9.77M
Operating revenue
6.47%48.13M
-8.03%11.77M
15.30%12.22M
13.23%12.61M
8.04%11.53M
22.78%45.21M
26.00%12.8M
12.02%10.6M
4.64%11.14M
62.74%10.67M
Excise taxes
-7.34%3.01M
-6.34%709K
-3.63%770K
2.03%804K
-19.67%723K
-13.65%3.24M
-26.29%757K
-16.34%799K
-25.73%788K
26.05%900K
Cost of revenue
6.86%31.16M
-14.93%7.17M
33.06%8.89M
22.30%8.48M
-6.97%6.62M
7.16%29.16M
21.50%8.43M
9.69%6.68M
-20.58%6.93M
30.50%7.12M
Gross profit
9.08%13.97M
7.69%3.89M
-17.88%2.56M
-2.57%3.33M
57.75%4.18M
118.70%12.81M
64.66%3.62M
29.09%3.12M
299.77%3.42M
585.01%2.65M
Operating expense
-5.57%22.38M
6.76%5.87M
-18.50%4.75M
19.01%7.13M
-27.49%4.62M
0.40%23.7M
18.91%5.5M
-13.94%5.83M
-29.38%5.99M
71.40%6.38M
Selling and administrative expenses
-6.00%21.49M
2.56%5.08M
-17.57%4.51M
20.76%7.16M
-27.20%4.73M
-7.82%22.86M
-26.47%4.95M
-14.10%5.48M
-26.33%5.93M
78.76%6.5M
-Selling and marketing expense
-4.47%2.91M
23.99%-865K
-17.32%1.16M
-5.98%1.37M
-6.02%1.25M
-3.70%3.04M
26.58%-1.14M
-16.60%1.4M
-12.66%1.46M
-2.92%1.33M
-General and administrative expense
-6.23%18.58M
-2.40%5.95M
-17.65%3.36M
29.45%5.79M
-32.65%3.48M
-8.43%19.81M
-26.49%6.09M
-13.21%4.08M
-29.90%4.48M
128.12%5.17M
Research and development costs
-5.11%223K
48.57%52K
-62.70%47K
70.37%46K
65.96%78K
12.44%235K
-40.68%35K
106.56%126K
-49.06%27K
30.56%47K
Depreciation amortization depletion
4.87%452K
----
----
----
----
-4.86%431K
----
----
----
----
-Depreciation and amortization
4.87%452K
----
----
----
----
-4.86%431K
----
----
----
----
Provision for doubtful accounts
155.42%46K
----
----
----
----
95.68%-83K
----
----
----
----
Other operating expenses
-33.85%170K
47.27%243K
-16.37%189K
-336.36%-78K
-10.18%-184K
289.39%257K
123.57%165K
-32.74%226K
-91.32%33K
-434.00%-167K
Operating profit
22.80%-8.41M
-4.99%-1.98M
19.20%-2.19M
-47.69%-3.8M
88.16%-441K
38.63%-10.89M
22.43%-1.89M
37.82%-2.71M
66.27%-2.57M
-11.76%-3.73M
Net non-operating interest income (expenses)
46.96%169K
-49.35%39K
169.70%46K
400.00%30K
-52.63%54K
-75.79%115K
-38.89%77K
-364.00%-66K
-112.66%-10K
-53.47%114K
Non-operating interest income
-66.43%232K
-40.82%58K
-63.31%62K
-79.00%42K
-68.75%70K
-17.74%691K
-56.83%98K
-2.87%169K
5.82%200K
-10.40%224K
Non-operating interest expense
-89.06%63K
-9.52%19K
-93.19%16K
-94.29%12K
-85.45%16K
57.81%576K
-79.21%21K
57.72%235K
90.91%210K
2,100.00%110K
Other net income (expenses)
-134.15%-28K
-97.90%82K
Gain on sale of security
-180.43%-37K
----
----
----
----
110.09%46K
----
----
----
----
Special income (charges)
-75.00%9K
----
----
----
----
-99.18%36K
1.33%-296K
--0
--0
----
-Less:Restructuring and mergern&acquisition
----
----
----
----
----
--0
--0
--0
--0
----
-Less:Impairment of capital assets
--0
----
----
----
----
-61.75%70K
----
----
----
----
-Less:Write off
-39.47%115K
----
----
----
----
375.00%190K
----
----
----
----
-Gain on sale of business
----
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
-58.11%124K
----
----
----
----
70.11%296K
----
----
----
----
Income before tax
22.69%-8.27M
-14.02%-1.97M
22.78%-2.14M
-45.95%-3.77M
89.28%-387K
19.95%-10.69M
43.59%-1.73M
35.94%-2.77M
10.34%-2.58M
-16.94%-3.61M
Income tax
0
0
0
Earnings from equity interest net of tax
Net income
22.69%-8.27M
-14.02%-1.97M
22.78%-2.14M
-45.95%-3.77M
89.28%-387K
18.26%-10.69M
38.07%-1.73M
35.89%-2.77M
10.34%-2.58M
-16.94%-3.61M
Net income continuous operations
22.69%-8.27M
-14.02%-1.97M
22.78%-2.14M
-45.95%-3.77M
89.28%-387K
18.26%-10.69M
38.07%-1.73M
35.89%-2.77M
10.34%-2.58M
-16.94%-3.61M
Noncontrolling interests
Net income attributable to the company
22.69%-8.27M
-14.02%-1.97M
22.78%-2.14M
-45.95%-3.77M
89.28%-387K
18.26%-10.69M
38.07%-1.73M
35.89%-2.77M
10.34%-2.58M
-16.94%-3.61M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
22.69%-8.27M
-14.02%-1.97M
22.78%-2.14M
-45.95%-3.77M
89.28%-387K
18.26%-10.69M
38.07%-1.73M
35.89%-2.77M
10.34%-2.58M
-16.94%-3.61M
Diluted earnings per share
33.33%-0.02
0
0.00%-0.01
0.00%-0.01
90.68%-0.0009
25.00%-0.03
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.01
Basic earnings per share
33.33%-0.02
0
0.00%-0.01
0.00%-0.01
90.68%-0.0009
25.00%-0.03
0.00%-0.01
0.00%-0.01
0.00%-0.01
0.00%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 7.54%45.12M-8.14%11.06M16.84%11.45M14.09%11.81M10.59%10.81M26.92%41.96M31.88%12.04M15.20%9.8M8.00%10.35M67.23%9.77M
Operating revenue 6.47%48.13M-8.03%11.77M15.30%12.22M13.23%12.61M8.04%11.53M22.78%45.21M26.00%12.8M12.02%10.6M4.64%11.14M62.74%10.67M
Excise taxes -7.34%3.01M-6.34%709K-3.63%770K2.03%804K-19.67%723K-13.65%3.24M-26.29%757K-16.34%799K-25.73%788K26.05%900K
Cost of revenue 6.86%31.16M-14.93%7.17M33.06%8.89M22.30%8.48M-6.97%6.62M7.16%29.16M21.50%8.43M9.69%6.68M-20.58%6.93M30.50%7.12M
Gross profit 9.08%13.97M7.69%3.89M-17.88%2.56M-2.57%3.33M57.75%4.18M118.70%12.81M64.66%3.62M29.09%3.12M299.77%3.42M585.01%2.65M
Operating expense -5.57%22.38M6.76%5.87M-18.50%4.75M19.01%7.13M-27.49%4.62M0.40%23.7M18.91%5.5M-13.94%5.83M-29.38%5.99M71.40%6.38M
Selling and administrative expenses -6.00%21.49M2.56%5.08M-17.57%4.51M20.76%7.16M-27.20%4.73M-7.82%22.86M-26.47%4.95M-14.10%5.48M-26.33%5.93M78.76%6.5M
-Selling and marketing expense -4.47%2.91M23.99%-865K-17.32%1.16M-5.98%1.37M-6.02%1.25M-3.70%3.04M26.58%-1.14M-16.60%1.4M-12.66%1.46M-2.92%1.33M
-General and administrative expense -6.23%18.58M-2.40%5.95M-17.65%3.36M29.45%5.79M-32.65%3.48M-8.43%19.81M-26.49%6.09M-13.21%4.08M-29.90%4.48M128.12%5.17M
Research and development costs -5.11%223K48.57%52K-62.70%47K70.37%46K65.96%78K12.44%235K-40.68%35K106.56%126K-49.06%27K30.56%47K
Depreciation amortization depletion 4.87%452K-----------------4.86%431K----------------
-Depreciation and amortization 4.87%452K-----------------4.86%431K----------------
Provision for doubtful accounts 155.42%46K----------------95.68%-83K----------------
Other operating expenses -33.85%170K47.27%243K-16.37%189K-336.36%-78K-10.18%-184K289.39%257K123.57%165K-32.74%226K-91.32%33K-434.00%-167K
Operating profit 22.80%-8.41M-4.99%-1.98M19.20%-2.19M-47.69%-3.8M88.16%-441K38.63%-10.89M22.43%-1.89M37.82%-2.71M66.27%-2.57M-11.76%-3.73M
Net non-operating interest income (expenses) 46.96%169K-49.35%39K169.70%46K400.00%30K-52.63%54K-75.79%115K-38.89%77K-364.00%-66K-112.66%-10K-53.47%114K
Non-operating interest income -66.43%232K-40.82%58K-63.31%62K-79.00%42K-68.75%70K-17.74%691K-56.83%98K-2.87%169K5.82%200K-10.40%224K
Non-operating interest expense -89.06%63K-9.52%19K-93.19%16K-94.29%12K-85.45%16K57.81%576K-79.21%21K57.72%235K90.91%210K2,100.00%110K
Other net income (expenses) -134.15%-28K-97.90%82K
Gain on sale of security -180.43%-37K----------------110.09%46K----------------
Special income (charges) -75.00%9K-----------------99.18%36K1.33%-296K--0--0----
-Less:Restructuring and mergern&acquisition ----------------------0--0--0--0----
-Less:Impairment of capital assets --0-----------------61.75%70K----------------
-Less:Write off -39.47%115K----------------375.00%190K----------------
-Gain on sale of business ----------------------0----------------
-Gain on sale of property,plant,equipment -58.11%124K----------------70.11%296K----------------
Income before tax 22.69%-8.27M-14.02%-1.97M22.78%-2.14M-45.95%-3.77M89.28%-387K19.95%-10.69M43.59%-1.73M35.94%-2.77M10.34%-2.58M-16.94%-3.61M
Income tax 000
Earnings from equity interest net of tax
Net income 22.69%-8.27M-14.02%-1.97M22.78%-2.14M-45.95%-3.77M89.28%-387K18.26%-10.69M38.07%-1.73M35.89%-2.77M10.34%-2.58M-16.94%-3.61M
Net income continuous operations 22.69%-8.27M-14.02%-1.97M22.78%-2.14M-45.95%-3.77M89.28%-387K18.26%-10.69M38.07%-1.73M35.89%-2.77M10.34%-2.58M-16.94%-3.61M
Noncontrolling interests
Net income attributable to the company 22.69%-8.27M-14.02%-1.97M22.78%-2.14M-45.95%-3.77M89.28%-387K18.26%-10.69M38.07%-1.73M35.89%-2.77M10.34%-2.58M-16.94%-3.61M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 22.69%-8.27M-14.02%-1.97M22.78%-2.14M-45.95%-3.77M89.28%-387K18.26%-10.69M38.07%-1.73M35.89%-2.77M10.34%-2.58M-16.94%-3.61M
Diluted earnings per share 33.33%-0.0200.00%-0.010.00%-0.0190.68%-0.000925.00%-0.030.00%-0.010.00%-0.010.00%-0.010.00%-0.01
Basic earnings per share 33.33%-0.0200.00%-0.010.00%-0.0190.68%-0.000925.00%-0.030.00%-0.010.00%-0.010.00%-0.010.00%-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More